Adicet Bio, Inc.
ACET
Rank in Stocks
#25142
Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic... Adicet Bio, Inc. is a biotechnology firm dedicated to pioneering allogeneic gamma delta T cell therapies, aiming to treat cancer and various other diseases. The companyโs strategy involves engineering gamma delta T cells with chimeric antigen receptors (CARs) and T cell receptor-like antibodies. This advanced modification is designed to achieve more precise targeting of tumors, enhance the body's natural and acquired immune responses against cancer, and provide sustained therapeutic benefits for patients. ADI-001, its most advanced therapeutic candidate, is presently in a Phase I clinical trial for individuals with non-Hodgkin's lymphoma. Additionally, Adicet Bio is developing ADI-002, which is undergoing preclinical investigations for its potential in treating a range of solid tumors. The company is headquartered in Boston, Massachusetts.
Share Price
$2.99
Last synced: 2026-11-09
Market Cap
$27.99M
Change (1 day)
-1.97%
Change (1 year)
-71.08%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Adicet Bio, Inc. (ACET)
Category
Healthcare
EPS for Adicet Bio, Inc. (ACET)
EPS as of September 2026 TTM: $-8.57
According to Adicet Bio, Inc.'s latest financial reports, its current EPS (TTM) is $-8.57. At the end of 2025 the company had an EPS of $-16.95, an increase over its 2024 EPS of $-21.28.
EPS history for Adicet Bio, Inc. from 2008 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-8.57 | -49.44% |
| 2025 | $-16.95 | -20.35% |
| 2024 | $-21.28 | -59.82% |
| 2023 | $-52.96 | 94.71% |
| 2022 | $-27.20 | -15.00% |
| 2021 | $-32.00 | -60.08% |
| 2020 | $-80.16 | 229.61% |
| 2019 | $-24.32 | 390.32% |
| 2018 | $-4.96 | -75.40% |
| 2017 | $-20.16 | 3,359,900.00% |
| 2016 | 0.00 | -100.00% |
| 2015 | $18.88 | 25.53% |
| 2014 | $15.04 | 0.00% |
| 2013 | $15.04 | 28.77% |
| 2012 | $11.68 | 82.50% |
| 2011 | $6.40 | 33.33% |
| 2010 | $4.80 | -25.00% |
| 2009 | $6.40 | -36.51% |
| 2008 | $10.08 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -282.73% |
US
|
|
| $-7.07 | -17.50% |
US
|
|
| $-5.29 | -38.27% |
AU
|
|
| $12.88 | -250.29% |
BE
|
|
| $21.56 | -351.58% |
NL
|
Questions about Adicet Bio, Inc.'s earnings per share (EPS)
What is Adicet Bio, Inc.'s earnings per share (EPS)?
Adicet Bio, Inc.'s earnings per share (EPS) over the last twelve months is $-8.57, as of Sep 2026.
What was Adicet Bio, Inc.'s earnings per share (EPS) in 2025?
In 2025, Adicet Bio, Inc.'s earnings per share (EPS) was $-16.95, compared with $-21.28 in 2024.
How has Adicet Bio, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Adicet Bio, Inc.'s earnings per share (EPS) was highest in 2025 ($-16.95) and lowest in 2020 ($-80.16).
How does Adicet Bio, Inc.'s earnings per share (EPS) compare with similar companies?
Adicet Bio, Inc.'s earnings per share (EPS) ($-8.57) is lower than that of all 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.